Schütte, W., Schirmacher, P., & Thomas, M. (2015). EGFR mutation status and first-line treatment in patients with stage III/IV non-small cell lung cancer in Germany: An observational study. Cancer epidemiology, biomarkers & prevention, 24(8), . https://doi.org/10.1158/1055-9965.EPI-14-1149
Chicago-Zitierstil (17. Ausg.)Schütte, Wolfgang, Peter Schirmacher, und Michael Thomas. "EGFR Mutation Status and First-line Treatment in Patients with Stage III/IV Non-small Cell Lung Cancer in Germany: An Observational Study." Cancer Epidemiology, Biomarkers & Prevention 24, no. 8 (2015). https://doi.org/10.1158/1055-9965.EPI-14-1149.
MLA-Zitierstil (9. Ausg.)Schütte, Wolfgang, et al. "EGFR Mutation Status and First-line Treatment in Patients with Stage III/IV Non-small Cell Lung Cancer in Germany: An Observational Study." Cancer Epidemiology, Biomarkers & Prevention, vol. 24, no. 8, 2015, https://doi.org/10.1158/1055-9965.EPI-14-1149.